Evidence map›Paper›PMID 29570050›Full record

ArticleeLife2018

Forniceal deep brain stimulation induces gene expression and splicing changes that promote neurogenesis and plasticity.

Amy E Pohodich, Hari Yalamanchili, Ayush T Raman, Ying-Wooi Wan, Michael Gundry, Shuang Hao, Haijing Jin, Jianrong Tang, Zhandong Liu, Huda Y Zoghbi

Open access · goldAbstract read
In one paragraph

Article in eLife, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 2 pooled it
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 2 syntheses or guidelines pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Biomarker changes associated with fornix deep brain stimulation in Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Neural plasticity and depression treatment.IBRO neuroscience reports · 2023
    Article
  14. MeCP2 regulateseLife · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Emerging Trends in Neuromodulation for Treatment of Drug-Resistant Epilepsy.Frontiers in pain research (Lausanne, Switzerland) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Amy E PohodichDepartment of Neuroscience, Baylor College of Medicine, Houston, United States.ORCID http://orcid.org/0000-0002-1802-7995
Hari YalamanchiliJan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, United States.
Ayush T RamanJan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, United States.
Ying-Wooi WanJan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, United States.
Michael GundryDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States.
Shuang HaoJan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, United States.
Haijing JinJan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, United States.
Jianrong TangJan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, United States.
Zhandong LiuJan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, United States.
Huda Y ZoghbiDepartment of Neuroscience, Baylor College of Medicine, Houston, United States.ORCID http://orcid.org/0000-0002-0700-3349
Baylor College of Medicine · USHoward Hughes Medical Institute · US

Funding

Steps towards a paternal gene activation therapy for Angelman syndromeU54HD083092 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI NELSON, DAVID LOREN, NEUL, JEFFREY L · 2014 to 2019
$7.8M
MOLECULAR PATHOGENESIS STUDIES OF RETT SYNDROMER01NS057819 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI ZOGHBI, HUDA Y · 2006 to 2025
$7.5M
Howard Hughes Medical Institute HHMI InvestigatorNICHD NIH HHS U54 HD083092NIH HHS 5R01NS057819NINDS NIH HHS R01 NS057819
6 · The paper itself

Abstract

Clinical trials are currently underway to assess the efficacy of forniceal deep brain stimulation (DBS) for improvement of memory in Alzheimer's patients, and forniceal DBS has been shown to improve learning and memory in a mouse model of Rett syndrome (RTT), an intellectual disability disorder caused by loss-of-function mutations in

Indexed as

Gene Expression ProfilingAnimalsDeep Brain StimulationFemaleFornix, BrainGene Regulatory NetworksMajor Depressive DisorderMaleMethyl-CpG-Binding Protein 2Mice, 129 StrainMice, KnockoutNeurogenesisNeuronal PlasticityRett SyndromeRNA SplicingMecp2 protein, mouseMethyl-CpG-Binding Protein 2forniceal deep brain stimulationhippocampusintellectual disabilityMeCP2mouseneurogenesisneuroscienceRett syndrome

Identifiers

PMID29570050
PMCPMC5906096
OpenAlexW2791311088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.